Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-Term Follow-Up Study of ADVM-022 in Diabetic Macular Edema- INFINITY Extension

NCT05607810 is registered in ClinicalTrials.gov with Adverum Biotechnologies, Inc. as lead sponsor.

NCT NCT05607810
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05607810 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-Term Follow-Up Study of ADVM-022 in Diabetic Macular Edema- INFINITY Extension
Lead sponsor
Adverum Biotechnologies, Inc.
Phase
Observational
Overall status
Active, not recruiting
Start date
August 10, 2022
Completion date
April 30, 2026
Enrollment
22 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema, diabetic retinopathy